Positive Baseline and follow-up QFT-GIT | ||
---|---|---|
Variables | Adjusted OR* (95% CI) | p-value |
Age categorized# | 5.0 (3.9-13.5) | 0.001 |
Sex | ||
Female | 1 | - |
Male | 1.2 (0.2-6.3) | 0.80 |
Birth in high-burden country | ||
No | 1 | - |
Yes | 0.2 (0.0-3.6) | 0.29 |
BCG status | 1 | - |
Vaccinated | 0.3 (0.1-1.5) | 0.15 |
Unknown | 0.6 (0.0-9.8) | 0.70 |
Profession | ||
Other | 1 | - |
Nursing | 0.6 (0.1-3.4) | 0.57 |
Physician | 3.2 (0.5-22.7) | 0.24 |
Affiliation with ID/TB Care | ||
No | 1 | - |
Yes | 0.8 (0.1-7.8) | 0.85 |
Family history of TB | ||
No | 1 | - |
Yes | 1.1 (0.1-8.7) | 0.96 |
QFT-GIT test interval per day | 1.0 (0.99-1.01) | 0.49 |
Exposure per hour§ | 0.7 (0.45-1.13) | 0.15 |
Prior TST | ||
Negative | 1 | - |
Positive | 14.2 (1.4-143.2) | 0.024 |
Recent TST | ||
Negative | 1 | - |
> 5 mm induration | 12.1 (2.4-59.8) | 0.002 |
≥ 10 mm induration | 15.5 (3.1-81.3) | 0.001 |
Baseline IFN-γ increase per 0.1 IU/ml | 1.03 (1.01-1.04) | 0.0006 |